BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Balance Sheet of Mankind Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 41.26 | 40.06 | 40.06 | 40.06 | 40.06 | |
| Total Share Capital | 41.26 | 40.06 | 40.06 | 40.06 | 40.06 | |
| Reserves and Surplus | 14,291.13 | 9,299.84 | 7,395.16 | 6,115.17 | 4,681.94 | |
| Total Reserves and Surplus | 14,291.13 | 9,299.84 | 7,395.16 | 6,115.17 | 4,681.94 | |
| Total Shareholders Funds | 14,332.39 | 9,363.09 | 7,435.22 | 6,155.23 | 4,722.00 | |
| Minority Interest | 235.79 | 212.70 | 188.07 | 161.08 | 140.89 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 5,526.19 | 24.87 | 23.15 | 52.18 | 62.18 | |
| Deferred Tax Liabilities [Net] | 1,812.51 | 89.07 | 77.31 | 55.62 | 13.03 | |
| Other Long Term Liabilities | 34.03 | 30.68 | 30.67 | 20.15 | 8.89 | |
| Long Term Provisions | 155.06 | 123.12 | 97.89 | 80.00 | 72.24 | |
| Total Non-Current Liabilities | 7,527.79 | 267.74 | 229.02 | 207.96 | 156.35 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 2,956.84 | 171.17 | 139.49 | 820.89 | 178.48 | |
| Trade Payables | 1,133.40 | 1,102.99 | 1,008.18 | 1,076.38 | 666.97 | |
| Other Current Liabilities | 909.45 | 456.26 | 407.84 | 461.70 | 273.73 | |
| Short Term Provisions | 663.87 | 389.31 | 307.63 | 264.50 | 234.22 | |
| Total Current Liabilities | 5,663.56 | 2,119.73 | 1,863.14 | 2,623.47 | 1,353.40 | |
| Total Capital And Liabilities | 27,759.53 | 11,963.25 | 9,715.45 | 9,147.74 | 6,372.63 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 2,907.87 | 2,936.91 | 2,529.17 | 1,725.14 | 1,625.58 | |
| Intangible Assets | 9,604.03 | 1,588.34 | 1,701.46 | 1,842.61 | 18.43 | |
| Capital Work-In-Progress | 306.13 | 207.09 | 493.19 | 669.87 | 371.62 | |
| Fixed Assets | 13,337.57 | 4,807.04 | 4,780.78 | 4,269.22 | 2,015.95 | |
| Non-Current Investments | 351.09 | 309.81 | 270.95 | 235.01 | 205.80 | |
| Deferred Tax Assets [Net] | 107.89 | 80.40 | 29.78 | 39.29 | 49.01 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.03 | 0.07 | |
| Other Non-Current Assets | 482.08 | 177.76 | 286.05 | 176.93 | 174.71 | |
| Total Non-Current Assets | 20,771.26 | 5,395.03 | 5,387.58 | 4,740.92 | 2,466.00 | |
| CURRENT ASSETS | ||||||
| Current Investments | 1,690.84 | 2,258.11 | 1,075.47 | 874.46 | 1,306.17 | |
| Inventories | 2,093.71 | 1,553.46 | 1,498.46 | 1,760.24 | 1,183.54 | |
| Trade Receivables | 1,538.34 | 848.28 | 576.42 | 388.17 | 330.61 | |
| Cash And Cash Equivalents | 554.50 | 1,197.97 | 453.20 | 405.94 | 700.74 | |
| Short Term Loans And Advances | 3.95 | 2.86 | 1.63 | 1.19 | 18.41 | |
| OtherCurrentAssets | 1,106.93 | 707.54 | 722.69 | 976.82 | 367.16 | |
| Total Current Assets | 6,988.27 | 6,568.23 | 4,327.87 | 4,406.82 | 3,906.64 | |
| Total Assets | 27,759.53 | 11,963.25 | 9,715.45 | 9,147.74 | 6,372.63 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 5,304.33 | 329.78 | 167.78 | 211.93 | 183.16 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | 160.19 | 120.52 | 0.00 | 0.00 | 0.00 | |
| Non-Current Investments Unquoted Book Value | 0.00 | 0.00 | 89.54 | 235.01 | 205.40 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 1,690.84 | 2,258.11 | 1,075.47 | 874.46 | 0.00 | |
| Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 1,306.17 |
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
11.11.2025
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
07.11.2025
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y